Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Minvasys to focus on innovative systems:

This article was originally published in Clinica

Executive Summary

A focus on developing innovative systems will be among the business aims of Minvasys, a new name in the French interventional vascular device sector. The company was formed in May, following the acquisition by Pierre Hilaire of all the share capital of Cathnet-Science France. Mr Hilaire is the president and managing director of Minvasys, which has 28 staff and headquarters in central Paris. The company will seek to combine its industry expertise and experience in serving the interventional medical community in Europe and worldwide, via its international business partners. Europe, Asia and Latin America are the company's main markets. Minvasys will continue to manufacture and market the haemostatic valve, SuperKetch, PTCA balloons, stent devices and a neuroradiology line.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT062679

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel